Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients WithPseudomonas aeruginosaInfection-Reference-Cited by-同舟云学术

Development and Assessment of Risk Scores for Carbapenem and Extensive β-Lactam Resistance Among Adult Hospitalized Patients WithPseudomonas aeruginosaInfection

Published:2018-10-26 Issue:6 Volume:1 Page:e183927
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Tartof Sara Y.¹,Kuntz Jennifer L.²,Chen Lie H.¹,Wei Rong¹,Puzniak Laura³,Tian Yun¹,Im Theresa M.¹,Takhar Harpreet S.¹,Merchant Sanjay³,Lodise Thomas⁴

Affiliation:

1. Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena

2. Kaiser Permanente Center for Health Research, Portland, Oregon

3. Merck Sharp & Dohme Corp, Kenilworth, New Jersey

4. Albany College of Pharmacy and Health Sciences, Albany, New York

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

http:///jamanetworkopen/article-pdf/1/6/e183927/17298896/tartof_2018_oi_180180.pdf

Reference24 articles.

1. Pseudomonas aeruginosa: all roads lead to resistance.;Breidenstein;Trends Microbiol,2011

2. The new ß-lactamases.;Jacoby;N Engl J Med,2005

3. Clinically significant carbapenemases: an update.;Walsh;Curr Opin Infect Dis,2008

4. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?;Livermore;Clin Infect Dis,2002

5. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.;Kang;Clin Infect Dis,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended β-lactam-resistant Pseudomonas aeruginosa;Journal of Antimicrobial Chemotherapy;2024-04-06

2. Management strategies for severe Pseudomonas aeruginosa infections;Current Opinion in Infectious Diseases;2023-10-12

3. Crossroads of Antimicrobial and Diagnostic Stewardship: Assessing Risks to Develop Clinical Decision Support to Combat Multidrug-Resistant Pseudomonas;Open Forum Infectious Diseases;2023-09-30

4. Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract Infection;Open Forum Infectious Diseases;2023-06-14

5. Prevalence and susceptibility profile of carbapenem-resistant pseudomonas aeruginosa (CRPA) at Dr. Soetomo Public Hospital, Surabaya, from January to December 2021;Bali Medical Journal;2023-02-04